Bullisch
$318.99
Szenariopreis
$282.640
+1.498 (+0.53%)Zum Schluss
Primerica, Inc., together with its subsidiaries, is a diversified financial services distribution company serving middle-income households in the United States and Canada. The Company’s operating segments include Term Life Insurance and Investment and Savings Products, and Corporate and Other Distributed Products. The Term Life Insurance segment distributes the term life insurance products that it underwrites through its three-issuing life insurance company subsidiaries: Primerica Life Insurance Company, National Benefit Life Insurance Company, and Primerica Life Insurance Company of Canada. Investment and Savings Products. The Investment and Savings Products segment in United States distributes mutual funds, managed accounts, variable annuity, and fixed annuity products of several third-party companies. The Corporate and Other Distributed Products segment includes net investment income and also includes revenues and expenses related to other distributed products.
Currently, Primerica Inc is not a strong buy due to its high RSI of 73.137, indicating it may be overbought. The forward P/E ratio of 14.0449 suggests that while the stock is reasonably valued, it is not undervalued enough to warrant a buy at this moment. Additionally, the recent insider selling of 1,800 shares by the President raises concerns about executive confidence. However, the median analyst price target of $337.50 indicates a potential upside of 19.4% from the current price of $282.64, which could be appealing for long-term investors. The main risk is the recent downgrade by Truist, reducing the price target from $370 to $320, reflecting concerns over term life sales performance.
Truist
$320
2026-08-27
Truist
2026-08-27
Kursziel
$320
Morgan Stanley
$316
2026-08-24
Morgan Stanley
2026-08-24
Kursziel
$316
Keefe Bruyette
$335
2026-08-11
Keefe Bruyette
2026-08-11
Kursziel
$335
TD Cowen
$360
2026-07-22
TD Cowen
2026-07-22
Kursziel
$360
Keefe Bruyette
$305
2026-05-13
Keefe Bruyette
2026-05-13
Kursziel
$305
Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

Middle-Income Families Face Increasing Financial Pressure

Primerica Household Budget Index Data Update

Analysis of Primerica Household Budget Index Data

Primerica Household Budget Index Data Update

Analysis of Primerica Executive Stock Sale Impact
Primerica, Inc., together with its subsidiaries, is a diversified financial services distribution company serving middle-income households in the United States and Canada. The Company’s operating segments include Term Life Insurance and Investment and Savings Products, and Corporate and Other Distributed Products. The Term Life Insurance segment distributes the term life insurance products that it underwrites through its three-issuing life insurance company subsidiaries: Primerica Life Insurance Company, National Benefit Life Insurance Company, and Primerica Life Insurance Company of Canada. Investment and Savings Products. The Investment and Savings Products segment in United States distributes mutual funds, managed accounts, variable annuity, and fixed annuity products of several third-party companies. The Corporate and Other Distributed Products segment includes net investment income and also includes revenues and expenses related to other distributed products. It operates in the Financials sector (LIFE INSURANCE industry).
Currently, Primerica Inc is not a strong buy due to its high RSI of 73.137, indicating it may be overbought. The forward P/E ratio of 14.0449 suggests that while the stock is reasonably valued, it is not undervalued enough to warrant a buy at this moment. Additionally, the recent insider selling of 1,800 shares by the President raises concerns about executive confidence. However, the median analyst price target of $337.50 indicates a potential upside of 19.4% from the current price of $282.64, which could be appealing for long-term investors. The main risk is the recent downgrade by Truist, reducing the price target from $370 to $320, reflecting concerns over term life sales performance.
5 analysts cover PRI: 0 rate it Buy, 5 Hold and 0 Sell. The average price target is 303.50.
Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.